Schedule 13D ownership disclosure

SKYE BIOSCIENCE INC

Common Stock, par value $0.001 · CUSIP: 83086J200

Event date: 2024-12-17

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • 5AM Partners VII, LLCReported CIK 0001873545

    Shares: 9,872,599.00 · Class: 30.8%

  • 5AM Ventures VII, L.P.Reported CIK 0001844435

    Shares: 9,872,599.00 · Class: 30.8%

  • 5AM Partners II, LLCReported CIK 0001555952

    Shares: 1,745,962.00 · Class: 5.8%

  • 5AM Ventures II, L.P.Reported CIK 0001386509

    Shares: 1,679,685.00 · Class: 5.5%

  • 5AM Co-Investors II, L.P.Reported CIK 0001390376

    Shares: 66,277.00 · Class: 0.2%

  • Andrew J. SchwabReported CIK 0001598549

    Shares: 11,696,895.00 · Class: 36.4%

  • Kush ParmarReported CIK 0001664281

    Shares: 9,872,599.00 · Class: 30.8%

  • John D. DiekmanReported CIK 0001240357

    Shares: 1,745,962.00 · Class: 5.8%

  • Scott M. RocklageReported CIK 0001219014

    Shares: 1,745,962.00 · Class: 5.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-24-029910
Form type
SCHEDULE 13D/A
Filer
5AM Partners VII, LLC
CIK
CIK 1873545
Filed
Dec 19, 2024
Reporting period
Dec 17, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub